For the quarter ending 2026-03-31, ASPN had $17,013K increase in cash & cash equivalents over the period. $32,778K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -23,691 | -72,913 | -6,334 | -310,305 |
| Impairment of property, plant and equipment | - | 3,607 | -2 | 288,021 |
| Depreciation | 5,382 | 28,176 | 5,392 | 11,589 |
| Amortization of debt issuance costs | 1,720 | 1,074 | 951 | 1,612 |
| Provision for bad debt | -3 | 3,510 | -4 | 32 |
| Loss on disposal of property, plant and equipment | - | -18,162 | - | - |
| Stock-based compensation expense | 1,866 | 1,678 | 2,183 | 4,767 |
| Deferred taxes | -522 | -416 | - | - |
| Reduction in the carrying amount of operating lease right-of-use assets | -1,074 | -862 | -828 | -1,844 |
| Accounts receivable | 1,165 | -30,369 | -7,022 | -32,905 |
| Inventories | -7,195 | -4,788 | -9,078 | 4,564 |
| Prepaid expenses and other assets | -1,542 | -3,751 | 361 | -14,782 |
| Accounts payable | 1,447 | -3,723 | -1,151 | -14,579 |
| Accrued expenses | 5,015 | -2,400 | 21 | -20,931 |
| Deferred revenue | 35,319 | 435 | 200 | -1,575 |
| Operating lease liabilities | - | - | - | -1,896 |
| Operating lease and other liabilities | -1,034 | -825 | -4,684 | - |
| Net cash provided by operating activities | 34,145 | 16,135 | 15,035 | 1,702 |
| Capital expenditures | 1,367 | 2,464 | 9,102 | 25,883 |
| Net cash used in investing activities | -1,367 | -2,464 | -9,102 | -25,883 |
| Proceeds from employee stock option exercises | - | 302 | 1,185 | 231 |
| Repayment of lease and other finance obligations | 1,469 | 1,417 | 1,349 | 2,464 |
| Payments made for employee restricted stock tax withholdings | 196 | 94 | 69 | 602 |
| Fees and issuance costs from registered direct offering of common stock | - | 28 | - | - |
| Proceeds from employee stock purchase plan | - | 176 | - | - |
| Repayment of revolving line of credit | 7,600 | 0 | 14,800 | 13,200 |
| Repayment of term loan | 6,500 | 6,500 | 6,500 | 13,000 |
| Fees and issuance costs from offering of common stock | - | - | 0 | 28 |
| Net cash used in financing activities | -15,765 | -7,533 | -21,533 | -29,063 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 17,013 | 6,138 | -15,600 | -53,244 |
| Cash, cash equivalents and restricted cash at beginning of period | 158,570 | 152,432 | 221,276 | - |
| Cash, cash equivalents and restricted cash at end of period | 175,583 | 158,570 | 152,432 | - |
ASPEN AEROGELS INC (ASPN)
ASPEN AEROGELS INC (ASPN)